Dataset Information


CD1d1 intrinsic signaling in macrophages controls NLRP3 inflammasome expression during inflammation.

ABSTRACT: Dysregulation of immune responses in the gut often associates with inflammatory bowel diseases (IBD). Mouse CD1d1, an ortholog of human CD1d mainly participating in lipid-antigen presentation to NKT cells, is able to generate intrinsic signals upon stimulation. Mice with macrophage-specific CD1d1 deficiency (LymCD1d1-/- ) acquire resistance to dextran sodium sulfate (DSS)-induced colitis, attributing to the transcriptional inhibition of NLRP3 inflammasome components. The hyperactivation of NLRP3 inflammasome accounts for gut epithelial proliferation and intestine-blood barrier integrity. Mechanistically, occupancy by the natural ligand glycosphingolipid iGb3, CD1d1 responds with intracellular Ser330 dephosphorylation thus to reduce the Peroxiredoxin 1 (PRDX1)-associated AKT-STAT1 phosphorylation and subsequent NF-?B activation, eventually causing transcriptional down-regulation of Nlrp3 and its immediate substrates Il1b and Il18 in macrophages. Therefore, the counterbalancing role of CD1d1 in macrophages appears to determine severity of DSS-mediated colitis in mice. These findings propose new intervention strategies for treating IBD and other inflammatory disorders.

PROVIDER: S-EPMC7577718 | BioStudies |

REPOSITORIES: biostudies

Similar Datasets

| S-EPMC8262017 | BioStudies
| S-EPMC7453595 | BioStudies
| S-SCDT-EMBOR-2021-54453V1 | BioStudies
| S-EPMC9240698 | BioStudies
| S-EPMC5601702 | BioStudies
| S-EPMC6885517 | BioStudies
| S-EPMC6541497 | BioStudies
| S-EPMC5124666 | BioStudies
| S-EPMC8320763 | BioStudies
| S-EPMC5017608 | BioStudies